Project Details

• Title: Novel Single Chain Trispecific Immunotoxin D2C7-Mel-14 for GBM Therapy
• Date Proposed: 07/16/2010
• Amount Requested: $50,000.00
• Amount we Paid: $50,000.00
• Paid Date: 07/21/2010
• Stauts: Funded - and in progress!
• Research name: Dr Darell Bigner
• Hospital: The Brain Tumor Center At Duke
• Grey Ribbon Crusade Participants:
  • Musella Foundation For Brain Tumor Research & Information, Inc
  • Have A Chance Inc.
  • Unlocking Brain Tumors, Inc
• Simple Description: This new treatment will attempt to create an antibody against 3 common targets found in brain tumors which seeks out and kills only tumor cells.